The importance of Pseudomonas aeruginosa as an opportunistic pathogen in nosocomial infections has been increasing steadily. A variety of predisposing conditions, including immunosuppressed status, cystic fibrosis, and thermal burns, have made more patients susceptible to infection. As P. aeruginosa is resistant to many antibiotics, a major problem is early identification of patients who need antipseudomonal agents. Various assays, such as counterimmunoelectrophoresis (1, 2) and radioimmunoassay (15) , have been proposed as immunodiagnostic tests for P. aeruginosa in clinical specimens. However, most of these assays have been performed with antisera that are not specific for the antigens of P. aeruginosa (1, 2) or are not sensitive enough to detect the antigens in urine (15) or serum (2).
Recently, we have produced a monoclonal antibody (MAb) specific for alkaline phosphatase in Escherichia coli and Shigella strains (12, 13) . This enzyme protein is a dimer composed of two identical subunits. It is localized in the periplasmic space (19) or at the cell surface of the gramnegative envelope in association with lipopolysaccharides (8, 20) and is easily detected by the MAb in an immunofluorescence assay (12, 13) or an enzyme capture test (M. O. Husson, D. Izard, F. Gavini, and H. Leclerc, submitted for publication).
Because alkaline phosphatase of P. aeruginosa shows similar localization (4, 6) , this study was undertaken to produce specific MAbs against this enzyme. The specificity of the MAbs was tested against numerous bacterial species by enzyme-linked immunosorbent assay (ELISA), indirect immunofluorescence assay (IFI), and Western blotting (immunoblotting).
P. aeruginosa strains were grown at 30°C for 18 h in phosphate-limiting medium (3) as described by Garen and Levinthal (10) to derepress alkaline phosphatase synthesis. For the other Pseudomonas species, the medium was supplemented with 0.0135% yeast extract (Difco Laboratories, Detroit, Mich.) and adjusted to pH 7.4 (9) . Members of the * Corresponding author.
family Enterobacteriaceae and other gram-negative bacteria tested were inoculated in another phosphate-limiting medium with a slightly different composition and pH (10) .
Alkaline phosphatase of P. aeruginosa ATCC 10145 was purified by the method of Day and Ingram (7), with some modifications. Briefly, equal volumes of P. aeruginosa cultures were centrifuged (17,000 x g), and the pellets were suspended in equal volumes of 0.01 M Tris buffer-0.2 M MgCl, (pH 8.4). The magnesium extract was concentrated and dialyzed; this material was applied to a DEAE-Sephacel column and eluted with a linear (100 to 400 mM) gradient of Tris buffer (pH 8). Fractions containing enzymatic activity were purified by Sephadex G-100 (1.8 cm2 by 80 cm) chromatography and by chromatofocusing in 25 mM Tris-CH3COOH buffer containing 20 mM MgCl2 (pH 7.8). Purity was checked by sodium dodecyl sulfate-polyacrylamide gel electrophoresis. Alkaline phosphatase activity was assayed with 2 mg of the substrate p-nitrophenylphosphate in 1 M Tris buffer-10 mM MgCl, (pH 8.4) per ml at 410 nm as described previously (3).
BALB/c mice were initially immunized intraperitoneally with 10 ,ug of purified alkaline phosphatase in complete Freund adjuvant. They were boosted with 10 p.g of antigen every 3 weeks, with the last injection given 3 days before fusion, for a total of five injections.
BALB/c spleen cells were fused with SP20/Ag-14 myeloma cells. The cells were fused by a slight modification of a procedure described previously (24 ELISA was performed in 96-well U-shaped microdilution trays (Costar, Cambridge, Mass.). Before being coated with intact bacteria, microdilution plates were first activated with pOly-D-lysine (1 ,ug/50 ,ul per well; Sigma) as described by Peters et al. (26) . After the plates were washed twice with 0.01 M phosphate-buffered saline (PBS; pH 7.5), bacteria (5 x 108 cells per ml in PBS [pH 7.5]; 50 pl per well) were incubated for 1 h at 37°C. Then 100 ,ul of a 0.01% solution of glutaraldehyde was added, and the plates were incubated for an additional 10 min. The plates were washed twice with PBS (pH 7.5) and then saturated with gelatin (2%, wt/vol; Merck & Co., Inc., Rahway, N.J.). After three washings with PBS, 100 pi of undiluted culture supernatant was added to the wells, and incubation was continued for 60 min at 37°C. The wells were washed three times with PBS and then incubated with 100 ,ul of sheep anti-mouse biotinylated immunoglobulin (1/300 dilution in PBS; Amersham Laboratories, ,France). The complex peroxidase-streptavidin (1/ 1,200 dilution in PBS; Amersham) was added after three washes. Peroxidase activity was detected colorimetrically by addition of 0.04% o-phenylenediamine in citrate-phosphate buffer (pH 5) with 0.006% H202. The reaction was developed in the dark for 15 min at room temperature and stopped by the addition of 50 ,ul of 1.3 M H2SO4. A490 was measured in a micro-ELISA plate photometer (Autoreader MR 600; Dynatech Laboratories, Inc., Alexandria, Va.).
Positive parental wells were cloned twice by limiting dilution. Ascites fluid was produced by injecting BALB/c mice intraperitoneally with 0.5 ml ofpristane (Aldrich Chemical Co., Inc., Milwaukee, Wis.). After 2 weeks, the mice were injected with!5 x 106 twice-subcloned hybridoma cells. Ascites fluid was harvested after 7 days. Specificities were determined by the ELISA described above, using ascites fluid diluted 1/5,000 in PBS instead of culture supernatant.
Immunoglobulin isotypes of the MAbs were determined by immunoprecipitation with goat anti-mouse immunoglobulins Gi, G2ab, and G3 (Nordic Laboratories).
Alkaline phosphatase and other periplasmic proteins released from whole cells by 0.2 M MgCl2 as described by Ingram et al. (14) were analyzed by immunoblotting. Discontinuotis sodium dodecyl sulfate-polyacrylamide gel electrophoresis was performed in a modified Laemmli gel system (16) with a 4.5% stacking gel and a 10% separating gel. Protein staining with Coomassie brilliant blue gels was performed as previously described (30) . The electrophoretic transfer procedure described previously (29) Eight clones (3E3, 3C2, 3C4, 3C9, 2C8, 7C1, 6C1, and lB10) were established. The MAbs produced by these clones belonged to the immunoglobulin Gi subclass, as determined by immunodiffusion using class-specific anti-mouse immunoglobulin antibodies. In immunoblot assay, they reacted only with P. aeruginosa alkaline phosphatase that had a molecular weight of 68,000 (7) (Fig. 1) .
In (17, 18, 27, 29) or species-specific (11) MAbs against P. aeruginosa antigens. The first of these studies described murine MAbs specific for lipopolysaccharides from the relatively rare Homma 7 (Fisher It-3) serotype (27) and from some (18, 28) (11, 23) . They recognized all serotype strains but also cross-reacted with P. fliuorescens, P. putida, P. stutzeri, and P. chlororaphis. The MAb specific for outer membrane lipoprotein H2 was able to interact with a rough lipopolysaccharide-deficient mutant by an IFI technique but could not be used for diagnosis of P. aeruginosa because it showed no fluorescence on intact wild-type bacterial cells. The degree of expression in vivo of outer membrane proteins F and H remains to be determined. Meadow et al. (22) found that these proteins are particularly exposed on the cell surface of bacteria when their Oantigenic structure deteriorates. Three MAbs, 3E3, 3C4, and 6C1, described in this study showed specificities similar to those found by Meadow et al. Moreover, they detected individual bacterial cells in ELISA or IFI with no special treatment, and our first experiments show that alkaline phosphatase is found at the cell surface of clinical isolates (Husson et 
